Deleted Journal, Год журнала: 2023, Номер 2, С. 262 - 262
Опубликована: Дек. 30, 2023
Heart failure (HF) after a myocardial infarction (MI) is one of the most frequent complications and with highest mortality rate in population. Given this, importance finding appropriate biomarkers for diagnosis, prognosis treatment this condition. The review was carried out under an analytical approach, using PRISMA statement as methodology; documents were retrieved through Scopus, ScienceDirect PubMed databases, where 20 articles that met certain inclusion criteria recognized. In conclusion, it explained use standard such B-type natriuretic peptide (BNP) non-terminal pro-BNP clinical practice have limitations, especially due to their low specificity HF post-MI complication. Therefore, currently, reflect alteration cardiac integrity, injury necrosis, inflammatory biomarkers, fibrosis, biomechanical stress, other types non-coding RNAs are being investigated
Язык: Английский